HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Markus Moser Selected Research

CS1 peptide

1/2017An O-Glycosylation of Fibronectin Mediates Hepatic Osteodystrophy Through α4β1 Integrin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Markus Moser Research Topics

Disease

8Thrombosis (Thrombus)
11/2019 - 12/2007
7Neoplasms (Cancer)
01/2014 - 03/2002
4Inflammation (Inflammations)
01/2022 - 04/2003
4Infections
11/2020 - 04/2003
4Melanoma (Melanoma, Malignant)
09/2011 - 03/2002
3Multiple Sclerosis
01/2018 - 10/2014
3Fibrosis (Cirrhosis)
01/2017 - 04/2003
3Neoplasm Metastasis (Metastasis)
01/2014 - 11/2003
3Hemorrhage
05/2009 - 03/2009
2Atherosclerosis
11/2019 - 01/2008
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2018 - 10/2013
2Wounds and Injuries (Trauma)
01/2014 - 08/2010
2Prion Diseases (Transmissible Spongiform Encephalopathies)
12/2006 - 03/2002
1Leukemia
01/2022
1Autosomal Dominant Polycystic Kidney (ADPKD)
01/2021
1Kidney Diseases (Kidney Disease)
01/2021
1Cysts
01/2021
1Reperfusion Injury
11/2020
1Virus Diseases (Viral Diseases)
12/2019
1Atherosclerotic Plaque (Atheroma)
11/2019
1Leukocyte Disorders
01/2019
1Atrophy
01/2018
1Demyelinating Diseases (Demyelinating Disease)
01/2018
1Liver Diseases (Liver Disease)
01/2017
1Primary Immunodeficiency Diseases
11/2016
1Ganglion Cysts (Ganglion)
01/2016
1Neuroinflammatory Diseases
10/2014
1Fatty Liver
08/2014
1Alcoholic Fatty Liver
08/2014
1Hepatitis
08/2014
1Proteinuria
11/2013
1Bone Resorption
03/2011
1Char syndrome
01/2011
1Chronic Disease (Chronic Diseases)
08/2010
1Suppuration
05/2009
1Leukocytosis (Pleocytosis)
05/2009
1Type III Leukocyte Adhesion Deficiency
05/2009
1Chondrosarcoma
05/2009
1Bacterial Infections (Bacterial Infection)
03/2009
1Leukocyte-Adhesion Deficiency Syndrome
03/2009
1Thrombasthenia (Glanzmann Thrombasthenia)
03/2009
1Body Weight (Weight, Body)
04/2008
1Stroke (Strokes)
03/2008
1Myocardial Infarction
03/2008
1Vascular System Injuries
12/2007
1Neurodegenerative Diseases (Neurodegenerative Disease)
12/2006
1Scrapie
12/2006

Drug/Important Bio-Agent (IBA)

16IntegrinsIBA
11/2020 - 12/2007
12Proteins (Proteins, Gene)FDA Link
01/2022 - 03/2002
3LigandsIBA
11/2013 - 12/2007
3Glucose (Dextrose)FDA LinkGeneric
04/2008 - 11/2003
3Messenger RNA (mRNA)IBA
01/2004 - 04/2003
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
11/2020 - 08/2010
2CalciumIBA
11/2019 - 04/2003
2Coloring Agents (Dyes)IBA
01/2018 - 01/2017
2Protein Isoforms (Isoforms)IBA
01/2017 - 01/2004
2CholesterolIBA
08/2014 - 01/2008
2CollagenIBA
01/2014 - 05/2005
2Transcription Factors (Transcription Factor)IBA
01/2011 - 05/2009
2Peptide Hydrolases (Proteases)FDA Link
12/2006 - 03/2002
2Prion ProteinsIBA
12/2006 - 03/2002
1Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA
01/2022
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
01/2021
1Cisplatin (Platino)FDA LinkGeneric
01/2021
1integrin-linked kinaseIBA
11/2020
1Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA
11/2020
1Antiviral Agents (Antivirals)IBA
12/2019
1von Willebrand FactorIBA
11/2019
1Myelin-Oligodendrocyte GlycoproteinIBA
01/2018
1AutoantibodiesIBA
01/2018
1Myelin Basic ProteinIBA
01/2018
1CS1 peptideIBA
01/2017
1Phosphotransferases (Kinase)IBA
11/2016
1Cholera ToxinIBA
01/2016
1Fluorescent Dyes (Fluorescent Probes)IBA
01/2016
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
08/2015
1ProteomeIBA
12/2014
1AntibodiesIBA
10/2014
1Oligoclonal BandsIBA
10/2014
1Cytidine DeaminaseIBA
10/2014
1Immunoglobulin M (IgM)IBA
10/2014
1Immunoglobulin G (IgG)IBA
10/2014
1Biomarkers (Surrogate Marker)IBA
10/2014
1EnzymesIBA
10/2014
1Two-Pore ChannelsIBA
08/2014
1Collagen Type IV (Type IV Collagen)IBA
01/2014
1AutoantigensIBA
10/2013
1Interleukin-10 (Interleukin 10)IBA
09/2011
1MicroRNAs (MicroRNA)IBA
11/2010
1Receptor for Advanced Glycation End ProductsIBA
08/2010
1Integrin beta3 (GPIIIa)IBA
03/2009
1ElementsIBA
03/2008
1LDL Receptors (LDL Receptor)IBA
01/2008
1Apolipoproteins MIBA
01/2008
1HDL LipoproteinsIBA
01/2008
1TalinIBA
12/2007
1Hemostatics (Antihemorrhagics)IBA
12/2007

Therapy/Procedure

1Stents
11/2019
1Therapeutics
11/2019
1Glycemic Control
04/2008